MVP Act

Enumerated powers · passes

Congress has authority under Article I, Section 8, Clause 1 (Spending Clause) to provide for the general welfare, which includes establishing and modifying federal health care programs like Medicaid and Medicare. Additionally, the regulation of drug pricing in interstate commerce falls under Article I, Section 8, Clause 3 (Commerce Clause). The bill's provisions are directly tied to these federal programs and their administration, so the action is within enumerated powers.

Bill of Rights · passes

The bill does not implicate any of the first ten amendments. It does not restrict speech, religion, assembly, press, petition, arms, quartering, search and seizure, self-incrimination, due process, takings, trial rights, or cruel and unusual punishment. It is a regulatory measure affecting drug pricing and reporting, not individual liberties.

Individual liberty · passes

The bill does not restrict what individuals can do with their person, property, speech, labor, or belief. It imposes obligations on drug manufacturers and government agencies, not on private citizens. The burden of compliance falls on corporations participating in federal programs, which is a legitimate exercise of federal spending power. No individual right is restricted.

Decentralization · passes

The bill operates within the existing federal Medicaid and Medicare programs, which are inherently federal-state partnerships. While it does direct states on how they may cover drugs in inpatient settings via guidance, this is within the framework of a cooperative federal program. The federal government already has a role in setting drug pricing rules for these programs, and the bill does not consolidate new decision-making authority beyond what is necessary for the efficient administration of these programs. States retain flexibility in implementing the guidance, and the bill does not preempt state authority beyond the scope of the federal programs.

Due process and takings · passes

The bill does not deprive any person of life, liberty, or property without due process. It does not involve any taking of private property for public use without just compensation. The changes to drug pricing calculations are regulatory and do not constitute a taking. There is no bypass of procedural or substantive due process; the bill is a legislative change with prospective effect.